Recently, mitophagy-related genes (MRGs) such as PINK1, Parkin, FUNDC1, PHB2, and BNIP3 have developed as a potential target for the development of novel therapeutic strategies for overcoming cancer resistance [6]. This evidence concerns the gene PHB2 and cancer.